Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-054399
Filing Date
2025-03-14
Accepted
2025-03-14 07:00:14
Documents
4
Period of Report
2025-05-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A d836146dpre14a.htm PRE 14A 466827
2 GRAPHIC g836146dsp001.jpg GRAPHIC 233536
3 GRAPHIC g836146dsp002.jpg GRAPHIC 106751
4 GRAPHIC g836146g01g01.jpg GRAPHIC 585567
  Complete submission text file 0001193125-25-054399.txt   1731650
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39248 | Film No.: 25737606
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)